George Eric Davis Biomarin Pharmaceutical Inc (BMRN) insider trading activity

George Eric Davis is EVP, Chief Legal Officer of BIOMARIN PHARMACEUTICAL INC. Currently has a direct ownership of 82,915 shares of BMRN, which is worth approximately $4.71 Million. The most recent transaction as insider was on May 02, 2022, when has been sold 15,347 shares (Common Stock) at a price of $37.46 per share, resulting in proceeds of $574,899. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 82.9K

3.84% 3M change

47.65% 12M change

Total Value Held $4.71 Million

George Eric Davis Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
May 02 2022	BUY Exercise of conversion of derivative security	$574,899 $37.46 p/Share	15,347 Added 15.82%	81,686 Common Stock
Apr 29 2022	BUY Grant, award, or other acquisition	$21,282 $62.41 p/Share	341 Added 0.51%	66,339 Common Stock
Apr 25 2022	BUY Exercise of conversion of derivative security	$99,981 $37.46 p/Share	2,669 Added 3.89%	65,998 Common Stock
Mar 21 2022	SELL Open market or private sale	$498,226 $81.29 p/Share	6,129 Reduced 8.82%	63,329 Common Stock
Mar 16 2022	SELL Payment of exercise price or tax liability	$101,061 $80.72 p/Share	1,252 Reduced 1.77%	69,458 Common Stock
Mar 15 2022	SELL Payment of exercise price or tax liability	$648,858 $78.27 p/Share	8,290 Reduced 10.49%	70,710 Common Stock
Mar 15 2022	BUY Grant, award, or other acquisition	-	11,040 Added 12.26%	79,000 Common Stock
Mar 08 2022	BUY Grant, award, or other acquisition	-	9,370 Added 12.12%	67,960 Common Stock
Aug 02 2021	SELL Open market or private sale	$423,175 $76.69 p/Share	5,518 Reduced 8.61%	58,590 Common Stock
May 03 2021	SELL Open market or private sale	$365,896 $78.3 p/Share	4,673 Reduced 6.79%	64,108 Common Stock
Apr 30 2021	BUY Grant, award, or other acquisition	$21,282 $62.41 p/Share	341 Added 0.49%	68,781 Common Stock
Apr 19 2021	SELL Open market or private sale	$215,582 $79.58 p/Share	2,709 Reduced 3.81%	68,440 Common Stock
Apr 19 2021	BUY Exercise of conversion of derivative security	$71,761 $26.49 p/Share	2,709 Added 3.67%	71,149 Common Stock
Mar 22 2021	SELL Payment of exercise price or tax liability	$109,221 $78.52 p/Share	1,391 Reduced 1.99%	68,440 Common Stock
Mar 16 2021	SELL Payment of exercise price or tax liability	$96,667 $77.21 p/Share	1,252 Reduced 1.76%	69,831 Common Stock
Mar 15 2021	SELL Payment of exercise price or tax liability	$393,047 $78.39 p/Share	5,014 Reduced 6.59%	71,083 Common Stock
Mar 15 2021	BUY Grant, award, or other acquisition	-	10,420 Added 12.04%	76,097 Common Stock

GED

George Eric Davis

EVP, Chief Legal Officer

San Rafael, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BMRN shares.

Notify only if

Value

Insider Trading

Get notified when an Biomarin Pharmaceutical Inc insider buys or sells BMRN shares.

Notify only if

Operation

Value

Type

News

Receive news related to BIOMARIN PHARMACEUTICAL INC

Track Activities on BMRN

Account